News and Media

Press Releases


November 13, 2017
CRISPR Therapeutics and Casebia Collaborate with CureVac on mRNA for Gene-Editing Programs

September 27, 2017
Casebia Therapeutics Announces License and Collaboration Agreements with Seattle Children’s Research Institute

September 8, 2017
Casebia Therapeutics Strengthens Leadership Team with Two Key Appointments

June 28, 2017
Casebia Therapeutics names Robin A. Walker as Vice President, Head of Legal

May 11, 2017
Casebia Therapeutics Expands Leadership Team

March 14, 2017
CRISPR Therapeutics and Casebia Therapeutics Announce Commercial License Agreement with MaxCyte


November 1, 2016
Casebia Therapeutics Announces Appointment of James W. Burns, Ph.D. as President and Chief Executive Officer

In the News


May 3, 2018
Evolving Industry Partnerships and Investments in Cell and Gene Therapies


September 15, 2017
Boston Business Journal: Casebia Head of Legal Robin Walker named one of the 50 Most Influential People of Color in Healthcare & Life Sciences

Social Media

Casebia’s at @ASGCT today, are you? If so, come see our CSO, Andy Scharenberg chairing the “Gene Therapy Vector and Transgene Immunogenicity” education session today at 1:30pm CT.

CEO Jim Burns is at the Boston CEO Conference today @FSBoston participating in the “Therapeutic Market Focus” panel. He will be talking about gene editing and the future landscape of this dynamic industry. Catch the panel at 2pm at the @BiotechConf

Aloha from Honolulu! Abraham Scaria, Peter Nell, Barbara Wan, and Albena Kantardzhieva are engaging with their peers from around the world at the #ARVO2018 Annual Meeting to discuss and learn about each other’s sight-saving work. Enjoy the conference everyone! @ARVOinfo

What a great event last week! Casebia was proud to support an Evening of Hope to benefit the Biomedical Science Careers Program. Congratulations to all of the honorees. Casebia team with BSCP students Marcelina Nidaisy from Pine Manor College and Marcus Perry from Tufts Univ.

Amy Duross @vinetiworks leads our Technology Trends panel, discussing leading platforms across cell & gene therapy sector, feat @pfizer @casebiatx @BlueRockTx @Adaptimmune #CGDay18

See us on Twitter